Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO2VATE Trial Program.
Saved in:
| Title: | Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO |
|---|---|
| Authors: | Winkelmayer WC; Section of Nephrology, Baylor College of Medicine, Houston, TX., Burke SK; Akebia Therapeutics Inc, Cambridge, MA., Chertow GM; Stanford University School of Medicine, Stanford, CA., Eckardt KU; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany., Luo W; Akebia Therapeutics Inc, Cambridge, MA., Minga T; Akebia Therapeutics Inc, Cambridge, MA., Sarnak MJ; Division of Nephrology, Tufts Medical Center, Tufts University School of Medicine, Boston, MA., Roy-Chaudhury P; Division of Nephrology and Hypertension, University of North Carolina Kidney Center, NC, and WG (Bill) Hefner VA Medical Center, Salisbury, NC. |
| Source: | Kidney medicine [Kidney Med] 2025 Mar 19; Vol. 7 (5), pp. 100997. Date of Electronic Publication: 2025 Mar 19 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101756300 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-0595 (Electronic) Linking ISSN: 25900595 NLM ISO Abbreviation: Kidney Med Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
